Evidence map›Paper›PMID 41920370›Full record

SynthesisInternational orthopaedics2026

Surgical complications and periprosthetic fractures following femoral impaction grafting in revision hip arthroplasty: a systematic review and meta-analysis of 4686 hips.

Octavian Andronic, Rutenis Badikonis, Artsiom Klimko, Victor Yan Zhe Lu, Armando Hoch, Patrick O Zingg

Abstract readSystematic ReviewMeta-Analysis
PubMed Publisher
In one paragraph

Synthesis in International orthopaedics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Octavian Andronic *Balgrist University Hospital, University of Zurich, Zurich, Switzerland. octavian.andronic@balgrist.ch.
Rutenis Badikonis *University of Zurich, Zurich, Switzerland. rutenis.badikonis@gmail.com.
Artsiom KlimkoBalgrist University Hospital, University of Zurich, Zurich, Switzerland.
Victor Yan Zhe LuChinese University of Hong Kong, Hong Kong, China.
Armando HochBalgrist University Hospital, University of Zurich, Zurich, Switzerland.
Patrick O ZinggBalgrist University Hospital, University of Zurich, Zurich, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo evaluate the incidence of surgical complications, particularly periprosthetic fractures, following femoral impaction bone grafting (fIBG) in revision total hip arthroplasty (rTHA).

methodsThis systematic review followed PRISMA guidelines. Studies reporting on fIBG in rTHA with a minimum follow-up of 12 months were included. Risk of bias was assessed using the Methodological Index for Non-Randomised Studies (MINORS). A random-effects meta-analysis with inverse-variance weighting was performed. Heterogeneity was assessed using Higgins and Thompson's I

resultsForty-five studies including 4,686 hips (4,409 patients) were analyzed. The pooled incidence of major complications was 21% (n = 730; 95% CI 16-26%; I

conclusionMajor complications following fIBG in rTHA are relatively frequent, although interpretation is limited by substantial study heterogeneity. Higher complication rates were observed in cases with severe bone loss and the use of long stems, likely reflecting greater surgical complexity.

Indexed as

Arthroplasty, Replacement, HipBone TransplantationFemurPeriprosthetic FracturesPostoperative ComplicationsHip ProsthesisHumansIncidenceReoperationFemoral bone lossFemoral reconstructionGraft incorporationHip stem revisionImpaction graftingRevision hip arthroplasty

Identifiers

PMID41920370

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.